Skip to main content

Day: May 15, 2025

Mount Logan Capital Inc. Announces First Quarter 2025 Financial Results

Declared quarterly distribution of C$0.02 per common share in the second quarter of 2025, the twenty-third consecutive quarter of a shareholder distribution Asset management segment generated $8.1 million in Fee Related Earnings (“FRE”) for the trailing twelve months ended March 31, 2025, a 25% increase over the prior year period Generated $7.8 million of Spread Related Earnings (“SRE”) for the trailing twelve months ended March 31, 2025, which reflects 1.3% of spread earnings on Ability’s assets During January 2025, the Company announced it entered into a definitive agreement to combine with 180 Degree Capital Corp. (Nasdaq: TURN) in an all-stock transaction. The surviving entity is expected to operate as Mount Logan Capital Inc. (“New Mount Logan”) and to be listed on Nasdaq under the symbol MLCI In January 2025, Mount Logan...

Continue reading

Sky Quarry Reports First Quarter 2025 Financial Results

WOODS CROSS, Utah, May 15, 2025 (GLOBE NEWSWIRE) — Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an integrated energy solutions company committed to revolutionizing the waste asphalt shingle recycling industry, today announced its financial and operational results for the three months ended March 31, 2025. Key Financial and Operational HighlightsGenerated $6.3 million in Q1 revenue, a 50% increase from Q4 2024. Signed a Letter of Intent with R & R Solutions, the only permitted asphalt shingle recycler in New Mexico, to explore the feasibility of establishing a modular waste-to-energy site in the Southwest. Executed a Letter of Intent with Southwind RAS, a leading recycler in the Midwest, to collaborate on regional facility deployment and feedstock supply. Engaged TAR360 to accelerate...

Continue reading

Calfrac Announces Voting Results of Election of Directors

CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) — Calfrac Well Services Ltd. (“Calfrac”) (TSX–CFW) is pleased to announce the voting results of the election of directors at its annual meeting of shareholders held today. Each of the nominees proposed as a director were elected as directors to hold office until the next annual meeting of shareholders, or until their successors are elected or appointed. Detailed results of the voting for each nominee are set out below, and the full results on all matters voted upon at the meeting will be filed on Calfrac’s profile on SEDAR+ (www.sedarplus.ca).Nominee Votes For Votes AgainstNumber % Number %Ronald P. Mathison 65,434,357 99.65 228,492 0.35Douglas R. Ramsay 65,447,107 99.67 215,742 0.33George S. Armoyan 63,552,876 96.79 2,109,973 3.21Anuroop Duggal 60,951,751 92.83 4,711,098 7.17Charles...

Continue reading

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2025.  On May 15, 2025, the Company closed an equity offering with gross proceeds of $5.0 million with a single institutional investor. Dr. Hing Wong, Founder and CEO, stated, “We are pleased to have completed a successful $5.0 million equity offering in a difficult market without using a highly structured deal. This funding will be used to open clinical sites for our Phase 1 clinical trial to evaluate HCW9302 in an autoimmune...

Continue reading

BioSyent Releases Financial Results for First Quarter 2025

MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include:(CAD) Q1 2025 % Change vs. Q1 2024 Trailing Twelve Months (TTM) Mar 31, 2025 % Change vs. TTM Mar 31, 2024Canadian Pharma Sales 9,159,652 +21 % 34,544,657 +13 %International Pharma Sales 1,535,216 n/a 2,465,191 +135 %Legacy Business Sales 284,092 +52 % 1,266,373 +15 %Total Company Sales 10,978,960 +42 % 38,276,221 +17 %EBITDA1 3,201,647 +45 % 10,340,466 +20 %Net Income After Taxes (NIAT) 2,319,933 +31 % 7,821,310 +11 %Fully Diluted EPS 0.20 +35 % 0.67 +14 %             Return on Average Equity for TTM March 31, 2025 was 22% as compared to 21% for TTM March 31, 2024 During Q1 2025, repurchased for...

Continue reading

BioSyent Declares Second Quarter 2025 Dividend

MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on June 13, 2025, to shareholders of record at the close of business on May 30, 2025. This second quarter 2025 dividend compares with the first quarter 2025 dividend of $0.05 per common share. This dividend qualifies as an ‘eligible dividend’ for Canadian income tax purposes. The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing...

Continue reading

Binah Capital Group Reports First Quarter 2025 Results

– Grew Total Revenue 18% Year-over-Year to $49 Million – – Assets Under Management (“AuM”) Increased 3% Year-over-Year to $26 Billion – – Net Income of $1 Million – – Increased EBITDA1 to $2.2 Million from $(0.0) Million in the Prior Year – NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Binah Capital Group, Inc. (“Binah”, “Binah Capital” or the “Company”) (NASDAQ: BCG; BCGWW), a leading financial services enterprise that owns and operates a network of industry-leading firms empowering independent financial advisors, today announced results for the quarter ended March 31, 2025. “We once again delivered strong results, which is a continued testament to our differentiated RIA platform,” stated Craig Gould, Chief Executive Officer of Binah Capital Group. “Highlighting our business model’s...

Continue reading

Banzai Reports First Quarter 2025 Financial Results

Revenue of $3.4 Million for Q1 2025, Representing 213% Growth from Q1 2024 Gross Profit of $2.8 Million for Q1 2025, Representing 297% Growth from Q1 2024; Gross Margin Expanded to 82.1% in Q1 2025 from 64.7% in Q1 2024 Q1 2025 Net Loss Improved to ($3.6) Million from ($7.9) Million in Q4 2024, Positioning the Company to Cash Break-Even Operations in FY2025 Management to Host First Quarter 2025 Results Conference Call Today, Thursday, May 15, 2025 at 5:45 p.m. Eastern Time SEATTLE, May 15, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Subsequent Key Financial & Operational Highlights...

Continue reading

SUNation Energy Announces 2025 First Quarter Results and Introduces Financial Guidance for 2025

Substantial Progress in Reducing Debt, Lowering Costs, Enhancing Cash FlowStrong Commercial Project Backlog RONKONKOMA, N.Y., May 15, 2025 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE) (the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). The information in this Press Release is not complete and should be carefully read in conjunction with our most recent Form 10-Q quarterly report for the financial quarter ended March 31, 2025, including the subsequent events and risk factor updated therein, as well as our other SEC reports. “Our results for Q1 2025 reflect the initial successes associated with our corporate transformation activities,...

Continue reading

ERES Declares May 2025 Monthly Distribution

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the May 2025 monthly cash distribution of €0.005 per Unit and Class B LP Unit (the “May 2025 Distribution”), being equivalent to €0.06 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on May 30, 2025, with payment on June 16, 2025. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.00774 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered Unitholders...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.